The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pretreatment neutrophil to lymphocyte ratio and prognosis of patients with advanced hepatocelullar carcinoma treated with sorafenib.
Leonardo Gomes Fonseca
No relevant relationships to disclose
Romualdo Barroso-Sousa
No relevant relationships to disclose
Bruna Paccola Blanco
No relevant relationships to disclose
Gabriel Luis Valente
No relevant relationships to disclose
Maria Ignez Freitas Melro Braghiroli
No relevant relationships to disclose
Tulio Eduardo Flesch Pfiffer
No relevant relationships to disclose
Jorge Sabbaga
No relevant relationships to disclose
Paulo Marcelo Hoff
No relevant relationships to disclose